SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences planning to acquire nine dermatology brands from Dr Reddy's Laboratories

16 Mar 2023 Evaluate

Eris Lifesciences is planning to acquire part of the dermatology portfolio of Dr Reddy's Laboratories by way of acquisition of nine trademarks along with their applicable line extensions (collectively referred to as Brands) for consideration of Rs 275 crore. The transaction helps augment and expand the cosmetic dermatology business of the company by way of expansion in the product offerings. The Transaction is to stand completed on or before March 31, 2023.

Eris Lifesciences develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives.

Eris Lifesciences Share Price

1388.05 17.75 (1.30%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×